Phibro Animal Health (NASDAQ:PAHC) Reaches New 1-Year High – Here’s What Happened

Phibro Animal Health Co. (NASDAQ:PAHC) shares reached a new 52-week high on Tuesday . The stock traded as high as $26.55 and last traded at $26.14, with a volume of 82337 shares changing hands. The stock had previously closed at $25.77.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on PAHC shares. Barclays raised their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Morgan Stanley increased their target price on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Finally, StockNews.com downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Phibro Animal Health presently has an average rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Price Performance

The firm’s fifty day simple moving average is $22.21 and its two-hundred day simple moving average is $22.07. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The firm has a market cap of $930.29 million, a PE ratio of 47.85, a P/E/G ratio of 0.51 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, research analysts expect that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.09%. Phibro Animal Health’s payout ratio is currently 100.00%.

Hedge Funds Weigh In On Phibro Animal Health

Institutional investors and hedge funds have recently modified their holdings of the stock. Millennium Management LLC lifted its stake in shares of Phibro Animal Health by 233.0% during the 4th quarter. Millennium Management LLC now owns 207,749 shares of the company’s stock worth $4,363,000 after acquiring an additional 145,359 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its position in shares of Phibro Animal Health by 56.7% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company’s stock worth $6,325,000 after purchasing an additional 108,918 shares during the last quarter. Hussman Strategic Advisors Inc. purchased a new stake in shares of Phibro Animal Health during the fourth quarter valued at $2,205,000. Nuveen Asset Management LLC grew its holdings in shares of Phibro Animal Health by 21.4% in the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock worth $12,348,000 after purchasing an additional 103,618 shares during the last quarter. Finally, Alliancebernstein L.P. grew its holdings in shares of Phibro Animal Health by 357.1% in the fourth quarter. Alliancebernstein L.P. now owns 130,000 shares of the company’s stock worth $2,730,000 after purchasing an additional 101,560 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.